FourThought Financial’s Novo Nordisk NVO Stock Holding History

FourThought Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$442K	Sell	8,868 -1,044	-11%	-$55.9K	0.07%	196
2022 Q2	$552K	Sell	9,912 -1,056	-10%	-$58.6K	0.08%	168
2022 Q1	$609K	Sell	10,968 -918	-8%	-$47.1K	0.08%	171
2021 Q4	$666K	Sell	11,886 -124	-1%	-$6.72K	0.08%	160
2021 Q3	$576K	Buy	12,010 +1,094	+10%	+$52.9K	0.08%	184
2021 Q2	$457K	Buy	10,916 +2,794	+34%	+$108K	0.06%	221
2021 Q1	$273K	Buy	8,122 +846	+12%	+$30.1K	0.04%	298
2020 Q4	$254K	Buy	+7,276	New	+$251K	0.04%	300

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

FourThought Financial's NVO Position: Q3 2022 in Review

FourThought Financial reduced its Novo Nordisk (NVO) stake by 11% in Q3 2022, selling an estimated $55.9K and leaving 8,868 shares worth $442K. The position accounts for 0.07% of the portfolio, ranked #196.

FourThought Financial first reported a position in NVO in Q4 2020 and has held it in 8 quarters since. The position peaked at $666K in Q4 2021. 908 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

FourThought Financial held 8,868 shares of Novo Nordisk worth $442K as of Q3 2022.
FourThought Financial sold 1,044 Novo Nordisk shares in Q3 2022, an estimated $55.9K.
Novo Nordisk made up 0.07% of FourThought Financial's portfolio in Q3 2022, its #196 holding.
FourThought Financial first reported a position in Novo Nordisk in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Novo Nordisk position peaked at $666K in Q4 2021.
908 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.